EP1242443A4 - Novel nucleic acids and polypeptides - Google Patents

Novel nucleic acids and polypeptides

Info

Publication number
EP1242443A4
EP1242443A4 EP00990231A EP00990231A EP1242443A4 EP 1242443 A4 EP1242443 A4 EP 1242443A4 EP 00990231 A EP00990231 A EP 00990231A EP 00990231 A EP00990231 A EP 00990231A EP 1242443 A4 EP1242443 A4 EP 1242443A4
Authority
EP
European Patent Office
Prior art keywords
polypeptides
nucleic acids
novel nucleic
novel
acids
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP00990231A
Other languages
German (de)
French (fr)
Other versions
EP1242443A1 (en
Inventor
Y Tom Tang
Chenghua Liu
Vinod Asundi
Rui-Hong Chen
Yunqing Ma
Xiaohong B Qian
Feiyan Ren
Dunrui Wang
Jian-Rui Wang
Zhiwei Wang
Tom Wehrman
Chongjun Xu
Aidong J Xue
Yonghong Yang
Jie Zhang
Qing A Zhao
Ping Zhou
Ryle Goodrich
Radoje T Drmanac
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nuvelo Inc
Original Assignee
Nuvelo Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/620,312 external-priority patent/US6569662B1/en
Application filed by Nuvelo Inc filed Critical Nuvelo Inc
Publication of EP1242443A1 publication Critical patent/EP1242443A1/en
Publication of EP1242443A4 publication Critical patent/EP1242443A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/775—Apolipopeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
EP00990231A 1999-12-23 2000-12-26 Novel nucleic acids and polypeptides Withdrawn EP1242443A4 (en)

Applications Claiming Priority (19)

Application Number Priority Date Filing Date Title
US662191 1991-02-28
US47127599A 1999-12-23 1999-12-23
US471275 1999-12-23
US48872500A 2000-01-21 2000-01-21
US488725 2000-01-21
US55231700A 2000-04-25 2000-04-25
US552317 2000-04-25
US59804200A 2000-06-20 2000-06-20
US598042 2000-06-20
US620312 2000-07-19
US09/620,312 US6569662B1 (en) 2000-01-21 2000-07-19 Nucleic acids and polypeptides
US65345000A 2000-08-31 2000-08-31
US653450 2000-08-31
US66219100A 2000-09-14 2000-09-14
US69303600A 2000-10-19 2000-10-19
US693036 2000-10-19
US72734400A 2000-11-29 2000-11-29
WOPCT/US72/07344 2000-11-29
PCT/US2000/034263 WO2001053312A1 (en) 1999-12-23 2000-12-26 Novel nucleic acids and polypeptides

Publications (2)

Publication Number Publication Date
EP1242443A1 EP1242443A1 (en) 2002-09-25
EP1242443A4 true EP1242443A4 (en) 2005-06-22

Family

ID=27578844

Family Applications (1)

Application Number Title Priority Date Filing Date
EP00990231A Withdrawn EP1242443A4 (en) 1999-12-23 2000-12-26 Novel nucleic acids and polypeptides

Country Status (3)

Country Link
EP (1) EP1242443A4 (en)
CA (1) CA2402563A1 (en)
WO (1) WO2001053312A1 (en)

Families Citing this family (198)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020137890A1 (en) * 1997-03-31 2002-09-26 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
AU2577799A (en) 1998-02-09 1999-08-23 Human Genome Sciences, Inc. 45 human secreted proteins
US6960433B1 (en) 1998-10-19 2005-11-01 Diadexus, Inc. Method of diagnosing, monitoring, staging, imaging and treating prostate cancer
US6369197B1 (en) 1998-11-20 2002-04-09 Millennium Pharmaceuticals, Inc. Potassium channel interactors and uses therefor
US7078481B1 (en) 1998-11-20 2006-07-18 Wyeth Potassium channel interactors and uses therefor
US7465785B2 (en) 1999-03-08 2008-12-16 Genentech, Inc. Polypeptide encoded by a nucleic acid over-expressed in melanoma
DK1632499T3 (en) * 1999-03-08 2007-10-01 Genentech Inc Gene sequences amplified in tumors and diagnostic applications thereof
US8410248B2 (en) 1999-03-12 2013-04-02 Human Genome Sciences Inc. HWBAO62 polypeptides
US7083791B2 (en) 1999-03-25 2006-08-01 Genesis Research & Development Corporation Limited Methods for enhancing immune responses by fibroblast growth factor receptor 5 polypeptides
US6242419B1 (en) * 1999-03-25 2001-06-05 Genesis Research & Development Corporation Ltd. Compositions isolated from stromal cells and methods for their use
US7034132B2 (en) 2001-06-04 2006-04-25 Anderson David W Therapeutic polypeptides, nucleic acids encoding same, and methods of use
EP1181374A4 (en) 1999-05-28 2003-04-23 Immunex Corp Novel murine and human kinases
EP1623993A3 (en) * 1999-09-01 2006-06-07 Genetech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
CA2391455A1 (en) * 1999-12-01 2001-06-07 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
US7423127B2 (en) * 1999-12-09 2008-09-09 Genentech, Inc. Antibodies to a polypeptide encoded by a nucleic acid overexpressed in melanoma
US20090176722A9 (en) 2000-01-28 2009-07-09 Shiv Srivastava Androgen-regulated PMEPA1 gene and polypeptides
ATE435277T1 (en) 2000-02-11 2009-07-15 Millennium Pharm Inc 18477, A HUMAN PROTEIN KINASE AND USE THEREOF
US6479270B1 (en) 2000-02-14 2002-11-12 Pe Corporation (Ny) Isolated human phosphatase proteins, nucleic acid molecules encoding human phosphatase proteins, and uses thereof
IL151211A0 (en) * 2000-02-17 2003-04-10 Aventis Pharma Sa Compositions useful for regulating parkin gene activity
JP2003525610A (en) * 2000-03-02 2003-09-02 キュラゲン コーポレイション Gene G12L related to thermal response
US20020111307A1 (en) * 2000-06-23 2002-08-15 Glucksmann Maria Alexandra 46508, a novel human peptidyl-tRNA hydrolase family member and uses thereof
US6569667B1 (en) 2000-04-26 2003-05-27 Millennium Pharmaceuticals, Inc. 26335, a novel human serine/threonine dehydratase and uses thereof
US20040214758A1 (en) 2000-03-24 2004-10-28 Meyers Rachel E. Novel human hydrolase family members and uses thereof
GB0018307D0 (en) 2000-07-26 2000-09-13 Aventis Pharm Prod Inc Polypeptides
AU4793101A (en) * 2000-03-31 2001-10-15 Aventis Pharm Prod Inc Nuclear factor kb inducing factor
AU2001253123A1 (en) * 2000-04-12 2001-10-30 The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services Identification of a renal nadph oxidase
WO2001079525A2 (en) * 2000-04-14 2001-10-25 Vanderbilt University Purified and isolated potassium-chloride cotransporter nucleic acids and polypeptides and therapeutic and screening methods using same
US20030083244A1 (en) * 2000-04-26 2003-05-01 Vernet Corine A.M. Novel proteins and nucleic acids encoding same
US20020177148A1 (en) * 2001-01-22 2002-11-28 Millennium Pharmaceuticals, Inc. FBH58295FL, a novel human amino acid transporter and uses thereof
US6461846B2 (en) * 2000-05-30 2002-10-08 Pe Corporation Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
DE10027170A1 (en) * 2000-05-31 2001-12-13 Schering Ag Human PEM as a target for fertility control
DE60132699T2 (en) 2000-06-06 2009-01-29 Bristol-Myers Squibb Co. NUCLEIC ACIDS AND POLYPEPTIDES RELATING TO B7 AND THEIR USES FOR IMMUNOMODULATION
WO2001096375A2 (en) * 2000-06-16 2001-12-20 Millennium Pharmaceuticals, Inc. 33358, a novel human ankyrin family member and uses thereof
FR2810673B1 (en) * 2000-06-26 2004-10-08 Univ Toulouse HUMAN MITOCHONDRIAL DYNAMINE MSP1 AND ITS USE IN THERAPEUTICS
WO2002002761A2 (en) * 2000-06-30 2002-01-10 Millennium Pharmaceuticals, Inc. 57658, a human uridine kinase and uses thereof
AU2002222937A1 (en) * 2000-07-18 2002-01-30 Millennium Pharmaceuticals, Inc. 14087, a serine protease molecule and uses therefor
WO2002008282A2 (en) * 2000-07-26 2002-01-31 Stanford University Bstp-ras/rerg protein and related reagents and methods of use thereof
CA2417087A1 (en) * 2000-08-01 2002-02-07 Oregon Health And Science University Mammalian dna binding membrane-associated protein-encoding gene and uses
AU2001283062A1 (en) 2000-08-02 2002-02-13 The Johns Hopkins University Endothelial cell expression patterns
WO2002012339A2 (en) * 2000-08-03 2002-02-14 Incyte Genomics, Inc. Sequences for integrin alpha-8
EP1710582A3 (en) * 2000-08-04 2006-11-02 Ludwig Institute For Cancer Research Suppressor genes
AU2001288466B2 (en) 2000-08-28 2007-03-29 Agensys, Inc. Nucleic acid and corresponding protein entitled 85P1B3 useful in treatment and detection of cancer
AU2001282109A1 (en) * 2000-08-31 2002-03-13 Bayer Aktiengesellschaft Regulation of human l-asparaginase-like enzyme
EP1328636A2 (en) * 2000-09-01 2003-07-23 Nuvelo Inc. Nucleic acids and polypeptides
WO2002018434A2 (en) * 2000-09-01 2002-03-07 The Governing Council Of The University Of Toronto Proteins related to schizophrenia and uses thereof
AU2001291135A1 (en) * 2000-09-19 2002-04-02 Millennium Pharmaceuticals, Inc. 63760, a novel human transporter and uses thereof
WO2002026945A2 (en) * 2000-09-27 2002-04-04 Bayer Aktiengesellschaft Regulation of human aminotransferase-like enzyme
WO2002026984A2 (en) * 2000-09-27 2002-04-04 Millennium Pharmaceuticals Inc. Potassium channel interactors and uses therefor
WO2002026957A2 (en) * 2000-09-28 2002-04-04 Bayer Aktiengesellschaft Regulation of a human serine protease
GB0024086D0 (en) * 2000-10-02 2000-11-15 Inpharmatica Ltd Proteinase
US6911336B2 (en) 2000-10-18 2005-06-28 Immunex Corporation GNK interacting amino acid decarboxylase and methods of use thereof
AUPR107800A0 (en) * 2000-10-27 2000-11-23 University Of Sydney, The Peptide and nucleic acid molecule ii
AUPR121300A0 (en) * 2000-11-03 2000-11-30 Monash University Cell division autoantigen (CDA) polypeptides, gene sequences and uses thereof
EP1364019A2 (en) * 2000-11-07 2003-11-26 Board of Regents, The University of Texas System Methods and compositions relating to muscle specific sarcomeric calcineurin-binding proteins (calsarcins)
CA2429376A1 (en) 2000-11-16 2002-10-17 Emory University Mitogenic oxygenase regulators
WO2002040651A2 (en) * 2000-11-17 2002-05-23 Bayer Aktiengesellschaft A human trna-specific adenosine deaminase
EP1209229A1 (en) * 2000-11-21 2002-05-29 Klaus-Peter Department of Psychiatry and Psychotherapy University of Würzburg Lesch Gene involved in schizophrenia
WO2002046228A2 (en) * 2000-12-05 2002-06-13 Wisconsin Alumni Research Foundation Receptor for b. anthracis toxin
US20040072997A1 (en) * 2000-12-20 2004-04-15 Alsobrook John P. Therapeutic polypeptides, nucleic acids encoding same, and methods of use
JPWO2002050269A1 (en) * 2000-12-21 2004-04-22 株式会社ジェノックス創薬研究所 Testing methods for allergic diseases
US20030166242A1 (en) * 2000-12-22 2003-09-04 Millennium Pharmaceuticals, Inc. 25828, a novel human aminopeptidase and uses therefor
WO2002053716A2 (en) * 2001-01-03 2002-07-11 Bayer Aktiengesellschaft Regulation of human ornithine decarboxylase
AUPR278301A0 (en) 2001-01-31 2001-02-22 Bionomics Limited A novel gene
WO2002057444A1 (en) * 2001-01-22 2002-07-25 Shinae Kondoh Human apoptosis-associated genes and human apoptosis-associated proteins produced thereby
US6686176B2 (en) * 2001-01-23 2004-02-03 Applera Corporation Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
US7601825B2 (en) 2001-03-05 2009-10-13 Agensys, Inc. Nucleic acid and corresponding protein entitled 121P1F1 useful in treatment and detection of cancer
JP2004521627A (en) * 2001-02-09 2004-07-22 インサイト・ゲノミックス・インコーポレイテッド Proteins associated with cell proliferation, cell differentiation and cell death
WO2002064777A2 (en) * 2001-02-14 2002-08-22 Axaron Bioscience Ag Proteins 7b6 and 11b4 and dna sequences encoding the same
WO2002064786A1 (en) * 2001-02-15 2002-08-22 Mochida Pharmaceutical Co., Ltd. Novel gene tcif
EP1575984A4 (en) 2001-02-16 2006-09-06 Bristol Myers Squibb Co Identification and cloning of a novel human gene, ret16, involved in the intracellular signaling cascade
US6461843B1 (en) 2001-02-16 2002-10-08 Applera Corporation Isolated nucleic acid molecules encoding human enzyme proteins, and uses thereof
GB0104440D0 (en) * 2001-02-22 2001-04-11 Oxford Biomedica Ltd Novel genes
US6924358B2 (en) 2001-03-05 2005-08-02 Agensys, Inc. 121P1F1: a tissue specific protein highly expressed in various cancers
JP2005508606A (en) * 2001-03-16 2005-04-07 インサイト・ゲノミックス・インコーポレイテッド Nucleic acid-related proteins
US8981061B2 (en) 2001-03-20 2015-03-17 Novo Nordisk A/S Receptor TREM (triggering receptor expressed on myeloid cells) and uses thereof
US8231878B2 (en) 2001-03-20 2012-07-31 Cosmo Research & Development S.P.A. Receptor trem (triggering receptor expressed on myeloid cells) and uses thereof
WO2002077219A1 (en) * 2001-03-26 2002-10-03 Lexicon Genetics Incorporated Novel human asparaginases and polynucleotides encoding the same
US6867019B2 (en) * 2001-03-27 2005-03-15 Applera Corporation Isolated human ras-like proteins, nucleic acid molecules encoding these human ras-like proteins, and uses thereof
CA2442134A1 (en) 2001-03-29 2002-10-10 Celltech R & D, Inc. Compositions and methods for diagnosing or treating psoriasis
US20030044813A1 (en) * 2001-03-30 2003-03-06 Old Lloyd J. Cancer-testis antigens
FR2823221B1 (en) 2001-04-06 2004-04-02 Univ Pasteur SEQUENCES ASSOCIATED WITH RETINAL DEGENERATION AND APPLICATIONS
AU2002308139A1 (en) * 2001-04-12 2002-10-28 Bayer Aktiengesellschaft Regulation of human methionine aminopeptidase-like protein
US20030022205A1 (en) * 2001-05-09 2003-01-30 Millennium Pharmaceuticals, Inc. 98359, a sodium channel beta 4 subunit, and uses therefor
US7335755B2 (en) * 2001-05-30 2008-02-26 Hisamitsu Pharmaceutical Co., Inc. Nucleic acids isolated in neuroblastoma
JP2005508614A (en) * 2001-07-06 2005-04-07 インサイト・ゲノミックス・インコーポレイテッド Drug metabolizing enzymes
EP1414954A2 (en) * 2001-07-09 2004-05-06 Kobenhavns Universitet Epsti1, a gene induced by epithelial-stromal interaction in human breast cancer
CA2453653A1 (en) * 2001-07-26 2003-02-06 Genset S.A. Gmg-2 polynucleotides and polypeptides and uses thereof
US7413870B2 (en) * 2001-08-01 2008-08-19 Rigel Pharmaceuticals, Incorporated SAK: modulation of cellular proliferation for treatment of cancer
FR2828209A1 (en) * 2001-08-01 2003-02-07 Cytomics Systems New nucleic acid encoding HECT-domain polypeptides, useful e.g. for treatment of cancer or inflammation, also new proteins, antibodies and modulators
US20030104385A1 (en) * 2001-08-02 2003-06-05 Evans Glen A. Nucleic acids and encoded polypeptides associated with bipolar disorder
WO2003018805A1 (en) * 2001-08-23 2003-03-06 Japan Science And Technology Agency Hematopoietic stem cell proliferation regulators and polynucleotides encoding the same
JP2003135063A (en) * 2001-08-24 2003-05-13 Chiba Prefecture New gene nedl-1
WO2003018804A1 (en) * 2001-08-27 2003-03-06 Japan Science And Technology Agency Proteins having effects of controlling cell migration and cell death
EP1427842A4 (en) * 2001-08-31 2005-06-15 Millenium Pharmaceuticals Inc Mid 9002, a human sulfatase family member and uses therefor
MXPA04002593A (en) * 2001-09-18 2004-05-31 Genentech Inc Compositions and methods for the diagnosis and treatment of tumor.
AU2008202000A1 (en) * 2001-09-18 2008-05-29 Genentech, Inc. Compositions and methods for the diagnosis and treatment of tumor
JP4232423B2 (en) * 2001-09-28 2009-03-04 第一三共株式会社 Novel ubiquitin-specific protease
MXPA04003155A (en) * 2001-10-03 2004-07-08 Inmunex Corp Human and murine cytokine polypeptides.
WO2003038093A2 (en) * 2001-10-30 2003-05-08 Bayer Healthcare Ag Regulation of human l-serine dehydratase
EP1440165A4 (en) * 2001-10-31 2005-03-30 Millennium Pharm Inc Methods and compositions for the treatment and diagnosis of cellular proliferation disorders using 25943
US7166713B2 (en) * 2001-12-11 2007-01-23 Texas Techn University Variant cleavage stimulation factor and its encoding nucleic acid
WO2003053364A2 (en) * 2001-12-19 2003-07-03 Millennium Pharmaceuticals, Inc. Methods and compositions in treating pain and painful disorders using 1465,1587, 2146, 2207, 32838, 336 and 52908
WO2003057867A2 (en) * 2002-01-10 2003-07-17 Bayer Healthcare Ag Regulation of human fatty acid coa ligase-like amp-binding enzyme
AU2003235632A1 (en) * 2002-01-16 2003-07-30 Bayer Aktiengesellschaft Regulation of human fatty acid coa ligase-like amp-binding enzyme
AU2003210158A1 (en) * 2002-01-16 2003-07-30 Bayer Aktiengesellschaft Regulation of human fatty acid coa ligase-like amp-binding enzyme
AU2003205174A1 (en) * 2002-01-17 2003-09-02 Incyte Genomics, Inc. Molecules for disease detection and treatment
WO2003072773A1 (en) * 2002-02-08 2003-09-04 Seikagaku Corporation Fused protein having glucuronyl transferase activity
JP2003250550A (en) * 2002-02-25 2003-09-09 Nissui Pharm Co Ltd Fat cell differentiation-related gene and protein
GB0206684D0 (en) * 2002-03-21 2002-05-01 Babraham Inst Novel proteins
US7193069B2 (en) 2002-03-22 2007-03-20 Research Association For Biotechnology Full-length cDNA
WO2003080825A2 (en) * 2002-03-27 2003-10-02 Bayer Healthcare Ag Further bmp-2 inducible kinases and the uses thereof
CA2480635A1 (en) * 2002-03-28 2003-10-09 Allen D. Delaney Cancer associated protein kinases and their uses
AU2003220804A1 (en) * 2002-03-29 2003-10-13 Nat Inst Of Advanced Ind Scien Novel galactose transferases, peptides thereof and nucleic acid encoding the same
US20050202431A1 (en) * 2002-04-01 2005-09-15 National Institute Of Advanced Industrial Science Application of kiaa0172 gene to treatment and diagnosis of diseases and drug discovery
JP2005536190A (en) * 2002-04-16 2005-12-02 ジェネンテック・インコーポレーテッド Compositions and methods for tumor diagnosis and treatment
WO2003093826A2 (en) * 2002-04-29 2003-11-13 Clinigenetics Assays for identifying cholesterol - lowering molecules
US7009038B2 (en) * 2002-05-02 2006-03-07 Univ. Of Medicine & Dentistry Of N.J. pDJA1, a cardiac specific gene, corresponding proteins, and uses thereof
EP1507553A2 (en) 2002-05-29 2005-02-23 DeveloGen Aktiengesellschaft für entwicklungsbiologische Forschung Pancreas-specific proteins
AU2003233246B2 (en) * 2002-06-07 2008-04-10 The Macfarlane Burnet Institute For Medical Research And Public Health Ltd FcyRIIa transgenic animal model for autoimmune disease
EP1560925A4 (en) * 2002-06-13 2006-10-25 Wyeth Corp Inhibitors of inflammatory gene activity and cholesterol biosynthesis
GB0214543D0 (en) * 2002-06-24 2002-08-07 Ares Trading Sa Proteins
WO2004002514A1 (en) * 2002-06-26 2004-01-08 Takeda Pharmaceutical Company Limited Preventives/remedies for cancer
US20060110384A1 (en) * 2002-07-10 2006-05-25 Yuji Matsuzawa Novel proteins and use thereof
JP2004097199A (en) * 2002-07-15 2004-04-02 Keio Gijuku Method for screening tumor antigen
AU2003281515A1 (en) * 2002-07-19 2004-02-09 Cellzome Ag Protein complexes of cellular networks underlying the development of cancer and other diseases
AU2003254081A1 (en) 2002-07-24 2004-02-09 New York University Truncated rgr in t cell malignancy
GB0217631D0 (en) * 2002-07-30 2002-09-11 Inpharmatica Ltd Proteins
WO2004013320A1 (en) * 2002-07-30 2004-02-12 Bayer Healthcare Ag Regulation of human methyltransferase
AU2003266271A1 (en) * 2002-08-13 2004-03-19 Bayer Healthcare Ag Regulation of human esterase
US20070269800A9 (en) * 2002-08-28 2007-11-22 Heinz Von Der Kammer Diagnostic and therapeutic use of foap-13 polynucleotides and polypeptides for neurodegenerative diseases
EP1396544A1 (en) * 2002-09-06 2004-03-10 Academisch Ziekenhuis Bij De Universiteit Van Amsterdam Nucleic acids encoding human thyroid dehalogenases
CA2498739A1 (en) * 2002-09-12 2004-03-25 Pharmexa A/S Immunization against autologous ghrelin
EP1556484A2 (en) * 2002-09-13 2005-07-27 Ingenium Pharmaceuticals AG Cytoplasmic dynein heavy chain 1 genes, expression products, non-human animal model: uses in human neurological diseases
AU2003266605A1 (en) * 2002-09-27 2004-04-19 Takeda Pharmaceutical Company Limited Preventives/remedies for neurodegenerative disease
US7662917B2 (en) 2002-09-30 2010-02-16 Ludwig Institute For Cancer Research Human sarcoma-associated antigens
US7560537B2 (en) * 2002-09-30 2009-07-14 Ludwig Institute For Cancer Research Human sarcoma-associated antigens
WO2004039980A1 (en) * 2002-10-30 2004-05-13 Cancer Research Technology Limited Agents modulating mal activity
WO2004039974A1 (en) * 2002-10-30 2004-05-13 Takeda Pharmaceutical Company Limited Novel protein and dna thereof
AU2003294438A1 (en) * 2002-11-21 2004-06-18 Wyeth Composition and method for treating lupus nephritis
GB0228337D0 (en) * 2002-12-05 2003-01-08 Yorkshire Cancer Res Campaign Replication protein
ATE498012T1 (en) 2002-12-24 2011-02-15 Univ Beijing HUMAN GENES RELATED TO CANCER, PRODUCTS ENCODED THEREOF, AND APPLICATIONS THEREOF
WO2004094617A2 (en) * 2003-02-21 2004-11-04 Phenomix Corporation Sensin polypeptides, encoding nucleic acids, mutations, and methods of their identification and use
JP4445291B2 (en) * 2003-03-10 2010-04-07 武田薬品工業株式会社 Novel protein and its DNA
AU2003901511A0 (en) * 2003-03-28 2003-04-17 Bionomics Limited Nucleic acid molecules associated with angiogenesis II
EP1464651A1 (en) * 2003-04-03 2004-10-06 Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts Dystrophin-related protein (Drop1), a marker for carcinomas
US7829682B1 (en) 2003-04-30 2010-11-09 Incyte Corporation Human β-adrenergic receptor kinase nucleic acid molecule
CN1244595C (en) * 2003-05-14 2006-03-08 中国科学院上海生命科学研究院 Tumor suppressor protein and its application
DE602004028249D1 (en) * 2003-06-18 2010-09-02 Chugai Pharmaceutical Co Ltd FUCOSETRANSPORTER
FR2843753A1 (en) * 2003-06-20 2004-02-27 Gene Signal Antisense nucleic molecule useful as inhibitor of angiogenesis in the treatment of angiogenic disorders, e.g., rheumatoid arthritis, atherosclerosis and endometriosis
WO2004113532A1 (en) * 2003-06-21 2004-12-29 Shigeki Higashiyama Protein for screening cytostatic agent, method of screening cytostatic agent and cytostatic agent
WO2005003336A2 (en) * 2003-07-07 2005-01-13 Universiteit Utrecht Holding B.V. Newly identified cholinephosphotransferases and ethanolaminephosphotransferases
US7294704B2 (en) 2003-08-15 2007-11-13 Diadexus, Inc. Pro108 antibody compositions and methods of use and use of Pro108 to assess cancer risk
EP1699478A2 (en) * 2003-09-23 2006-09-13 Meyer Pharmaceuticals, LLC Treating inflammation using a biological agent that causes cells to release cytokine receptors
JP2005168338A (en) * 2003-12-09 2005-06-30 Japan Science & Technology Agency New protein calphogrin, gene encoding the same, medicine, and target substance
US20050186577A1 (en) 2004-02-20 2005-08-25 Yixin Wang Breast cancer prognostics
JP4757194B2 (en) * 2004-03-19 2011-08-24 ジェノミディア株式会社 Vascular endothelial growth inhibitory gene
GB0407587D0 (en) * 2004-04-02 2004-05-05 Univ Nottingham Trent Cancer associated antigens
CN101061239B (en) * 2004-09-24 2011-08-17 肿瘤疗法科学股份有限公司 Method for diagnosing non-small cell lung cancers by tRNA-dihydrouridine synthase activity of URLC8
CA2588253A1 (en) * 2004-11-22 2006-06-08 Wyeth Methods and systems for prognosis and treatment of solid tumors
GB0426146D0 (en) 2004-11-29 2004-12-29 Bioxell Spa Therapeutic peptides and method
DE102004059781A1 (en) * 2004-12-10 2006-06-22 Sanofi-Aventis Deutschland Gmbh Use of serum / glucocorticoid-regulated kinase
WO2006085684A2 (en) 2005-02-10 2006-08-17 Oncotherapy Science, Inc. Method of diagnosing bladder cancer
EP1734118A1 (en) * 2005-06-15 2006-12-20 Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts Identification of JAK/STAT pathway modulating genes by genome wide RNAi screening
WO2007028631A1 (en) * 2005-09-09 2007-03-15 H. Lundbeck A/S Genetic risk factor for neurodevelopmental disorders and their complications
US20070071755A1 (en) * 2005-09-27 2007-03-29 David Balasundaram Novel nucleolar GTPases and method for controlling proliferation of cells
WO2007088639A1 (en) * 2006-02-01 2007-08-09 Hiroshima University Substrate protein for m-phase kinase and use thereof
EP1815863A1 (en) * 2006-02-03 2007-08-08 Nederlandse Organisatie voor toegepast-natuurwetenschappelijk Onderzoek TNO Use of TLR3 agonists for the treatment of neurodegenerative disorders
WO2007095113A2 (en) 2006-02-10 2007-08-23 Massachusetts Institute Of Technology Cpg15 and cpg15-2 compounds and inhibitors as insulin receptor and insulin-like growth factor receptor agonists and antagonists
US8933209B2 (en) 2006-04-26 2015-01-13 Abbvie Inc. Dep2 and its uses in major depressive disorder and other related disorders
JP2010520333A (en) 2007-03-01 2010-06-10 セダーズ−シナイ メディカル センター Antioxidant polymer containing [1,2] -dithiolane moiety and use thereof
EP2158327B1 (en) * 2007-06-03 2013-05-15 Oncotx, Inc. Cancer related isoforms of components of transcription factor complexes as biomarkers and drug targets
EP2027889A1 (en) * 2007-06-05 2009-02-25 Institut National De La Sante Et De La Recherche Medicale (Inserm) New neuronal viability factor and use thereof
WO2009086547A1 (en) 2008-01-03 2009-07-09 Cedars-Sinai Medical Center Antioxidant nanosphere comprising [1,2]-dithiolane moieties
KR20100124326A (en) 2008-03-14 2010-11-26 엑사젠 다이어그노스틱스, 인코포레이티드 Biomarkers for inflammatory bowel disease and irritable bowel syndrome
US8603531B2 (en) 2008-06-02 2013-12-10 Cedars-Sinai Medical Center Nanometer-sized prodrugs of NSAIDs
WO2010060098A1 (en) 2008-11-24 2010-05-27 Cedars-Sinai Medical Center Antioxidant camptothecin derivatives and antioxidant antineoplastic nanospheres thereof
PL2398902T3 (en) 2009-02-20 2024-02-26 Astellas Pharma Inc. Methods and compositions for diagnosis and treatment of cancer
CN111875703A (en) 2009-11-11 2020-11-03 安斯泰来制药股份有限公司 Antibodies specific for claudin 6(CLDN6)
EP2404936A1 (en) 2010-07-06 2012-01-11 Ganymed Pharmaceuticals AG Cancer therapy using CLDN6 target-directed antibodies in vivo
ES2565063T3 (en) 2011-05-13 2016-03-31 Ganymed Pharmaceuticals Ag Antibodies for the treatment of cancer that expresses claudin 6
WO2012157737A1 (en) * 2011-05-19 2012-11-22 東レ株式会社 Immunity inducing agent
WO2013104798A1 (en) * 2012-01-12 2013-07-18 Cemm - Center For Molecular Medicine Of The Austrian Academy Of Sciences Modulators of immune responses
WO2013120554A1 (en) 2012-02-15 2013-08-22 Novo Nordisk A/S Antibodies that bind peptidoglycan recognition protein 1
EP2814844B1 (en) 2012-02-15 2017-08-02 Novo Nordisk A/S Antibodies that bind and block triggering receptor expressed on myeloid cells-1 (trem-1)
US9550830B2 (en) 2012-02-15 2017-01-24 Novo Nordisk A/S Antibodies that bind and block triggering receptor expressed on myeloid cells-1 (TREM-1)
US20130288980A1 (en) * 2012-04-02 2013-10-31 Buck Institute For Research On Aging Targeting senescent and cancer cells for selective killing by interference with foxo4
WO2015014376A1 (en) 2013-07-31 2015-02-05 Biontech Ag Diagnosis and therapy of cancer involving cancer stem cells
BR112016030947A2 (en) 2014-07-17 2017-10-24 Novo Nordisk As site-directed mutagenesis of train-1 antibodies to decrease viscosity
EP2977758A1 (en) * 2014-07-24 2016-01-27 Université De Nice Sophia Antipolis Methods and kits for monitoring membranous nephropathy
US11054425B2 (en) 2014-12-19 2021-07-06 Roche Sequencing Solutions, Inc. System and method for identification and characterization of transglutaminase species
WO2016100735A1 (en) 2014-12-19 2016-06-23 Roche Nimblegen, Inc. Microbial transglutaminases, substrates therefor and methods for the use thereof
CA2971246C (en) * 2014-12-19 2020-07-14 F. Hoffmann-La Roche Ag Identification of transglutaminase substrates and uses therefor
GB201509134D0 (en) * 2015-05-28 2015-07-15 Electrophoretics Ltd Biomolecules involved in Alzheimer's disease
WO2017182395A1 (en) * 2016-04-21 2017-10-26 Immatics Biotechnologies Gmbh Immunotherapy against melanoma and other cancers
MX2018012758A (en) 2016-04-21 2019-01-31 Immatics Biotechnologies Gmbh Immunotherapy against melanoma and other cancers.
JP2021519594A (en) 2018-04-02 2021-08-12 ブリストル−マイヤーズ スクイブ カンパニーＢｒｉｓｔｏｌ−Ｍｙｅｒｓ Ｓｑｕｉｂｂ Ｃｏｍｐａｎｙ Anti-TREM-1 antibody and its use
GB201807831D0 (en) * 2018-05-15 2018-06-27 Univ College Cardiff Consultants Ltd Cancer Vaccine
EP4110350A4 (en) * 2020-02-27 2024-04-03 The George Washington Univ A Congressionally Chartered Not For Profit Corporation Cobra1/nelf-b as a booster for efficacy of cd8+ t cell-based therapy

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999046281A2 (en) * 1998-03-10 1999-09-16 Genentech, Inc. Novel polypeptides and nucleic acids encoding the same

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5175095A (en) * 1989-07-19 1992-12-29 Calgene, Inc. Ovary-tissue transcriptional factors

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999046281A2 (en) * 1998-03-10 1999-09-16 Genentech, Inc. Novel polypeptides and nucleic acids encoding the same

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
JACOBS K A ET AL: "A genetic selection for isolating cDNAs encoding secreted proteins", GENE: AN INTERNATIONAL JOURNAL ON GENES AND GENOMES, ELSEVIER SCIENCE PUBLISHERS, BARKING, GB, vol. 198, no. 1-2, 1 October 1997 (1997-10-01), pages 289 - 296, XP004570106, ISSN: 0378-1119 *
See also references of WO0153312A1 *

Also Published As

Publication number Publication date
EP1242443A1 (en) 2002-09-25
WO2001053312A8 (en) 2002-06-20
WO2001053312A1 (en) 2001-07-26
CA2402563A1 (en) 2001-07-26

Similar Documents

Publication Publication Date Title
EP1242443A4 (en) Novel nucleic acids and polypeptides
AU2001234944A8 (en) Novel nucleic acids and polypeptides
EP1325120A4 (en) Novel nucleic acids and polypeptides
EP1341804A4 (en) Novel nucleic acids and polypeptides
IL206414A0 (en) Novel receptor nucleic acids and polypeptides
AU2001249251A1 (en) Novel nucleic acids and polypeptides
AU2001243142A1 (en) Novel nucleic acids and polypeptides
AU2001290548A1 (en) Novel nucleic acids and polypeptides
AU2001245280A1 (en) Novel nucleic acids and polypeptides
AU2001233041A1 (en) Novel nucleic acids and polypeptides
EP1381621A4 (en) Novel nucleic acids and polypeptides
AU2001238347A1 (en) Novel nucleic acids and polypeptides
AU2001263006A1 (en) Novel nucleic acids and polypeptides
AU2001233017A1 (en) Novel nucleic acids and polypeptides
EP1276751A4 (en) Novel nucleic acids and polypeptides
EP1368475A4 (en) Novel nucleic acids and polypeptides
AU2001250872A1 (en) Novel nucleic acids and polypeptides
AU2001277840A1 (en) Novel nucleic acids and polypeptides
EP1341803A4 (en) Novel nucleic acids and polypeptides
EP1239039A4 (en) Novel polypeptide and dna thereof
AU3511100A (en) Novel nucleic acids and polypeptides
HUP0201660A2 (en) Novel polypeptide and dna thereof
AU2001263005A8 (en) Novel nucleic acids and polypeptides
EP1268762A4 (en) Novel nucleic acids and polypeptides
AU1453601A (en) Novel polypeptides and nucleic acids encoding same

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20020624

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR

AX Request for extension of the european patent

Free format text: AL;LT;LV;MK;RO;SI

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: NUVELO INC.

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: NUVELO, INC.

RIC1 Information provided on ipc code assigned before grant

Ipc: 7C 12N 15/11 B

Ipc: 7C 07K 14/00 B

Ipc: 7C 12N 15/63 B

Ipc: 7C 07H 21/04 A

Ipc: 7C 07K 14/435 B

Ipc: 7C 12N 15/70 B

A4 Supplementary search report drawn up and despatched

Effective date: 20050509

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN WITHDRAWN

18W Application withdrawn

Effective date: 20060111